Search
for
Sort by
Research 601–630 of 773
- Whole-genome resequencing to investigate the genetic diversity and the molecular basis underlying key economic traits in indigenous sheep breeds adapted to hypoxic environments
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- Baricitinib in Alopecia Areata: Real-Life Changes in Lipid Profile and Hematologic Inflammation Indices at 52 weeks
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- Baricitinib maintains regrowth of hair, eyebrows, and eyelashes over 3 years
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
- 397 Predictive modeling of drug response and mechanism of action in alopecia areata clinical trials
- Oral Tofacitinib in Refractory Pediatric Alopecia Areata
- Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata
- Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials
- Surgical Approaches for Repigmenting Vitiligo 2.0
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- The influence of interferon on healthy and diseased skin
- Alopecia Areata: An Update on Treatment Options for Children
- Selection signatures of wool color in Gangba sheep revealed by genome-wide SNP discovery
- Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- Impact of Combined Baricitinib and FTI Treatment on Adipogenesis in Hutchinson–Gilford Progeria Syndrome and Other Lipodystrophic Laminopathies
- Biologics in the management of childhood atopic dermatitis
- Baricitinib-loaded separable microneedle array patch (S-MAP) based on hyaluronic acid for alopecia areata therapy
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
- Exploring the Complexities of TGF-beta Signaling in Keloids: Beyond the Classical Smad Pathway
- Molecular crosstalk between lncRNA H19, miR-29a, and JAK2/STAT3 signaling in alopecia areata: a preliminary study
- Tissue Retinol‐Binding Protein 4 Expression and Its Genetic Variants (rs3758539) in Patients With Severe and Treatment‐Refractory Alopecia Areata: Association With Response to Baricitinib
- Systemic Absorption and Pharmacokinetics of Five Novel Topical Dermatologic Agents: A Review
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes
- Efficacy and Safety of Baricitinib in Patients With Alopecia Areata: A Real‐World Cohort Study
- Mesenchymal Stem Cell Therapy in Alopecia Areata: Visual and Molecular Evidence from a Mouse Model